The DOI matches its Crossref record.
Prospective study on quantitative and qualitative antimicrobial and anti-inflammatory drug use in white veal calves
Abstract
OBJECTIVES: To document and quantify drug use in white veal calves, an intensive livestock production system where multidrug resistance is abundantly present. METHODS: Drug consumption data were prospectively collected on 15 white veal production cohorts (n = 5853 calves) in Belgium (2007-09). Treatment incidences (TIs) based on animal defined daily dose (ADD), prescribed daily dose (PDD) and used daily dose (UDD) were calculated. Risk factors were identified by linear regression. RESULTS: The average TI(ADD) of antimicrobial treatments was 416.8 ADD per 1000 animals at risk. Predominantly, oral group antimicrobial treatments were used (95.8%). Of the oral group antimicrobial treatments, 12% and 88% were used for prophylactic or metaphylactic indications, respectively. The main indication for group and individual drug use was respiratory disease. The most frequently used antimicrobials (group treatments) were oxytetracycline (23.7%), amoxicillin (18.5%), tylosin (17.2%) and colistin (15.2%). Deviations from the leaflet dosage recommendations were frequently encountered, with 43.7% of the group treatments underdosed (often oxytetracycline and tylosin to treat dysbacteriosis). In 33.3% of the oral antimicrobial group treatments a combination of two antimicrobial preparations was used. Smaller integrations used more antimicrobials in group treatments than larger ones (P < 0.05); an integration is defined as a company that combines all steps of the production chain by having its own feed plant and slaughterhouse and by placing its calves in veal herds owned by producers that fatten these calves for this integration on contract. Producers used higher dosages than prescribed by the veterinarian in cohorts with a single caretaker (P < 0.01). CONCLUSIONS: The present study provided detailed information on the intensive antimicrobial use in the white veal industry. Reduction can only be achieved by reducing the number of oral group treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Global trends in antimicrobial use in food animals
Van Boeckel, T. P., Brower, C., Gilbert, M., Grenfell, B. T., Levin, S. A., Robinson, T. P., Teillant, A., & Laxminarayan, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503141112 · Cited by 3,973
Chantziaras, I., Boyen, F., Callens, B., & Dewulf, J. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt443 · Cited by 622
Self-citationEMA Committee for Medicinal Products for Veterinary Use (CVMP) and EFSA Panel on Biological Hazards (BIOHAZ), Murphy, D., Ricci, A., Auce, Z., Beechinor, J. G., Bergendahl, H., Breathnach, R., Bureš, J., Duarte Da Silva, J. P., Hederová, J., et al. (2017) · EFSA Journal · doi:10.2903/j.efsa.2017.4666 · Cited by 314
Self-citationColistin use and colistin resistance in bacteria from animals
Kempf, I., Jouy, E., & Chauvin, C. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.09.016 · Cited by 270
Pardon, B., Hostens, M., Duchateau, L., Dewulf, J., De Bleecker, K., & Deprez, P. (2013) · BMC Veterinary Research · doi:10.1186/1746-6148-9-79 · Cited by 138
Self-citation
Metadata
- Authors
- Pardon, B., Catry, B., Dewulf, J., Persoons, D., Hostens, M., De Bleecker, K., & Deprez, P.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-01-18
- Volume
- 67
- Issue
- 4
- Pages
- 1027-1038
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2096784278
- Cited by
- 188
- References
- 0
- FWCI
- 10.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prospective study on quantitative and qualitative antimicrobial and anti-inflammatory drug use in white veal calves. https://app.cochat.ai/papers/10.1093/jac/dkr570
- The paper
- Pardon, B., Catry, B., Dewulf, J., Persoons, D., Hostens, M., De Bleecker, K., & Deprez, P. (2012). Prospective study on quantitative and qualitative antimicrobial and anti-inflammatory drug use in white veal calves. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkr570
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.